Foil Tariff Preliminary Update: March 2023

Per a Federal Register notice published Mar. 22, 2023, the U.S. Department of Commerce preliminarily determines that imports of certain aluminum foil from the Republic of Korea and from the Kingdom of Thailand are circumventing duties.

Getty Images 83388218
Getty Images

In November 2022, we reported on potential foil tariffs from the Department of Commerce (DOC) which could have supply chain continuity effects on the healthcare packaging community. [Editor's note: this is a report on a preliminary determination, presented without comment.] 

Timeline

In December, the DOC extended its deadlines for circumvention inquiry as follows.

  • Preliminary determination: February 28, 2023
  • Final determination: July 18, 2023

However on February 27, 2023, the DOC further extended these dates to March 15, 2023, and August 2, 2023, for preliminary and final determination, respectively.

Preliminary affirmative determination

Per a notice by the International Trade Administration, “We preliminarily determine that aluminum foil, assembled or completed in Korea and Thailand by the entities identified in Appendix II to this notice, using Chinese-origin aluminum foil and/or sheet, that is subsequently exported from Korea or Thailand to the United States, is circumventing the Orders. For a detailed explanation of our determinations with respect to the entities identified in Appendix II, see the Preliminary Decision Memoranda and the “Use of Adverse Facts Available” section…”

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?